Predict your next investment

Corporate Venture
FINANCE | Lending
orix.com/capital-solution/growth-capital

See what CB Insights has to offer

Investments

72

Portfolio Exits

36

Funds

1

Partners & Customers

1

About ORIX Growth Capital

ORIX Growth Capital is a provider of highly customized equity and debt solutions for high-growth companies.

ORIX Growth Capital Headquarter Location

1717 Main Street Suite 1100

Dallas, Texas, 75201,

United States

214-237-2000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

ORIX Growth Capital Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ORIX Growth Capital Rank

Latest ORIX Growth Capital News

DrChrono Raises $12M in Funding

Jun 30, 2021

DrChrono , a Sunnyvale CA-based company focused on platform and services for modern medical practices, raised $12M in funding. The round was led by ORIX Growth Capital. The company intends to use the funds to: expand the telehealth offerings on the DrChrono platform, grow operations and enhance across the other key product areas including EHR, practice management, medical billing and its core partner API. DrChrono provides a platform which offers EHR, practice management, medical billing, revenue cycle management, and API solutions. It is currently used by thousands of physicians and has over 28 million patients under the care of DrChrono providers. The company has facilitated millions of appointments and the processing of more than $11 billion of medical billing to date. FinSMEs

ORIX Growth Capital Investments

72 Investments

ORIX Growth Capital has made 72 investments. Their latest investment was in PolicyGenius as part of their Line of Credit on March 3, 2022.

CBI Logo

ORIX Growth Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/17/2022

Line of Credit

PolicyGenius

Yes

1

10/20/2021

Debt

VFP Pharmacy Group

$12M

Yes

3

6/23/2021

Series C

DrChrono

$12M

No

7

1/13/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

8/7/2019

Debt

Subscribe to see more

Subscribe to see more

10

Date

3/17/2022

10/20/2021

6/23/2021

1/13/2020

8/7/2019

Round

Line of Credit

Debt

Series C

Series B

Debt

Company

PolicyGenius

VFP Pharmacy Group

DrChrono

Subscribe to see more

Subscribe to see more

Amount

$12M

$12M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

3

7

10

10

ORIX Growth Capital Portfolio Exits

36 Portfolio Exits

ORIX Growth Capital has 36 portfolio exits. Their latest portfolio exit was Mavenlink on November 17, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/17/2021

Merger

$99M

8

11/2/2021

Acquired

$99M

8

7/22/2021

Acquired

$99M

5

7/21/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

6/8/2021

Merger

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/17/2021

11/2/2021

7/22/2021

7/21/2021

6/8/2021

Exit

Merger

Acquired

Acquired

IPO

Merger

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

8

8

5

10

10

ORIX Growth Capital Fund History

1 Fund History

ORIX Growth Capital has 1 fund, including ORIX Venture Finance LLC.

Closing Date

Fund

Fund Type

Status

Amount

Sources

ORIX Venture Finance LLC

Multi-Stage Venture Capital

Closed

1

Closing Date

Fund

ORIX Venture Finance LLC

Fund Type

Multi-Stage Venture Capital

Status

Closed

Amount

Sources

1

ORIX Growth Capital Partners & Customers

1 Partners and customers

ORIX Growth Capital has 1 strategic partners and customers. ORIX Growth Capital recently partnered with Custom Ink on November 11, 2016.

Date

Type

Business Partner

Country

News Snippet

Sources

11/15/2016

Partner

United States

ORIX Growth Capital and Square 1 Bank Announce Expanded Banking and Credit Relationship With CustomInk

`` ORIX Growth Capital has been a terrific partner to CustomInk , and we 're delighted to expand that relationship to include Square 1 , '' said Kevin Cheetham , chief financial officer for CustomInk .

1

Date

11/15/2016

Type

Partner

Business Partner

Country

United States

News Snippet

ORIX Growth Capital and Square 1 Bank Announce Expanded Banking and Credit Relationship With CustomInk

`` ORIX Growth Capital has been a terrific partner to CustomInk , and we 're delighted to expand that relationship to include Square 1 , '' said Kevin Cheetham , chief financial officer for CustomInk .

Sources

1

ORIX Growth Capital Team

6 Team Members

ORIX Growth Capital has 6 team members, including current Managing Director, William Bishop.

Name

Work History

Title

Status

William Bishop

Managing Director

Current

Reinhard Freimuth

Managing Director

Current

David T. Orlandella

Fifth Street Asset Management, ORIX USA, Enhanced Capital Partners LLC, Redwood Ventures, and PwC

Managing Director

Current

Kevin P Sheehan

Chief Executive Officer, President

Former

Michael David

Managing Director

Former

Name

William Bishop

Reinhard Freimuth

David T. Orlandella

Kevin P Sheehan

Michael David

Work History

Fifth Street Asset Management, ORIX USA, Enhanced Capital Partners LLC, Redwood Ventures, and PwC

Title

Managing Director

Managing Director

Managing Director

Chief Executive Officer, President

Managing Director

Status

Current

Current

Current

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.